Research Triangle Park, N.C.
Pharmaceutical company Eisai Incorporated will expand its footprint in Research Triangle Park, N.C. with the construction of a 65,000-sf facility. Bringing the site to a total of 225,000-sf, the $90 million plant will accommodate research and development of intravenous drug production and formulation for cancer therapies. Eisai will also construct a $15 million central utilities plant to supply power, chilled water, steam, and compressed air for both new and existing buildings. Completion of the pharmaceutical plant expansion is expected in 2009.
